Flexion Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Flexion Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17% to $85,552,000. The net income raised on -$113,706,000 and profit margin reached -133%. Total operating expenses were $159,322,000.
Profit Margin
| 2011 | 0 | -11.44M | |
|---|---|---|---|
| 2012 | 0 | -14.98M | |
| 2013 | 0 | -18.18M | |
| 2014 | 0 | -27.31M | |
| 2015 | 0 | -46.31M | |
| 2016 | 0 | -71.89M | |
| 2017 | 355K | -137.48M | -38727.04% |
| 2018 | 22.52M | -169.65M | -753.24% |
| 2019 | 72.95M | -149.77M | -205.29% |
| 2020 | 85.55M | -113.70M | -132.91% |
FLXN Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 85.55M | 72.95M | 22.52M | 355K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 19.24M | 9.96M | 7.33M | 4K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 66.30M | 62.99M | 15.18M | 351K | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 54.32M | 69.55M | 53.07M | 51.23M | 41.31M | 32.69M | 17.92M | 11.06M | 11.06M | 8.24M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 159.32M | 199.26M | 174.39M | 130.03M | 69.78M | 46.06M | 26.98M | 17.76M | 15.01M | 0 |
Operating income | -93.01M | -136.27M | -159.20M | -129.68M | -69.78M | -46.06M | -26.98M | -17.76M | -15.01M | -11.28M |
Other income (expenses), net | -20.19M | -13.50M | -10.45M | -7.8M | -2.11M | -252.37K | -326.39K | -421.51K | 30.02K | 159.37K |
Income before tax | -113.21M | -149.77M | -169.65M | -137.48M | -71.89M | -46.31M | -27.31M | -18.18M | -14.98M | -11.44M |
Income tax expense | 495K | 3.56M | 5.25M | 3.46M | -366.48K | 318.61K | 74.98K | 27.37K | 0 | 0 |
Net income | -113.70M | -149.77M | -169.65M | -137.48M | -71.89M | -46.31M | -27.31M | -18.18M | -14.98M | -11.44M |
Earnings per share | ||||||||||
Basic EPS | -2.66 | -3.93 | -4.49 | -4.16 | -2.84 | -2.15 | -1.97 | -1.23 | -2.04 | -1.17 |
Diluted EPS | -2.66 | -3.93 | -4.49 | -4.16 | -2.84 | -2.15 | -1.97 | -1.23 | -2.04 | -1.17 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |